Bitcoin differs from other cryptocurrencies, says Jack Mallers
Bitcoin remains the dominant cryptocurrency and differs from the other coins and tokens currently available in the market. Jack Mallers, the CEO of Strike, a...
Beth Pinsker: This is what tax experts are telling clients who lost money on cryptocurrencies this year
The pain will be much greater for those who had money at failed exchanges such as FTX.
The Conversation: Why inequality is growing in the U.S. and around the world
The rich are getting much richer, thanks to large capital gains and favorable tax breaks
Metals Stocks: Gold prices flat as traders eye unrest in China
Gold prices for December delivery were flat in recent trade as traders eye burgeoning civil unrest in China.
Project Syndicate: The shortsighted world is not ready for the next evitable pandemic, and time is running out
Funding for health is again put on the back burner while countries tackle the inflation and fiscal crises caused by the last pandemic.
The Ratings Game: Activision stock looks undervalued with or without a Microsoft deal, says analyst
Wells Fargo analyst Brian Fitzgerald thinks that Activision's stock looks attractive regardless of whether the merger with Microsoft happens.
Axsome’s stock rallies 15% on promising findings for its experimental Alzheimer’s drug
Shares of Axsome Therapeutics Inc. jumped 15.5% in premarket trading on Monday after the company said its Alzheimer's treatment candidate met the primary and secondary...
Taboola stock rockets after 30-year agreement with Yahoo, making Yahoo the largest shareholder
Shares of Taboola.com Ltd. skyrocketed 53.3% to pace all premarket gainers Monday, after the provider of recommendations for online editorial content and advertisements announced an...
Sarepta expected to get FDA decision on Duchenne treatment by May 29
Shares of Sarepta Therapeutics Inc. were up 4.6% in premarket trading on Monday after the company said U.S. regulators accepted its application for accelerated approval...